- Brain Tumor Immunology: Part II : Immunotherapy of Malignant Brain Tumors
-
Hong YK, Rha HK, Jung CK, Lee SW, Jo TH, Baik MW, Yoon SH, Kang JK, Song JU, Choi CR
- KMID: 2067857
- J Korean Neurosurg Soc.
- 1990 Dec;19(10-12):1389-1396.
The prognosis of patients with malignant brain tumors has improved only slightly despite the combined use of surgery, radiation therapy, and chemotherapy. Immunotherapy offers some possibilities and hopes as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunotherapy for Renal Cell Carcinoma
-
Park DS
- KMID: 1481929
- J Korean Med Assoc.
- 2008 Jun;51(6):569-576.
- doi: 10.5124/jkma.2008.51.6.569
Since spontaneous regression of metastatic renal cell carcinoma (mRCC) has been reported, immunotherapy for mRCC has been the therapeutic option. The goal of modulating an immune response to the tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer Vaccines
-
Son EW, In SW, Pyo S
- KMID: 2150599
- Immune Netw.
- 2005 Jun;5(2):55-67.
- doi: 10.4110/in.2005.5.2.55
Cancer vaccine is an active immunotherapy to stimulate the immune system to mount a response against the tumor specific antigen. Working as a stimulant to the body's own immune system,... -
- CITED
-
- Close
- SHARE
-
- Close
- In Vitro Induction of Carcinoembryonic Antigen (CEA) Specific Cytotoxic T Lymphocytes Using Dendritic Cells Pulsed with CEA Peptide
-
Park MH, Lee CS, Cho MH, Han C, Koh YS, Kim JC, Yoon JH, Jegal YJ, Nam JH
- KMID: 2004324
- J Korean Surg Soc.
- 2005 Nov;69(5):359-366.
PURPOSE: Dendritic cells (DCs) are the most potent antigen- presenting cells for initiating the T cell immune response in vivo. Recent studies have shown that active immunotherapy with tumor antigen... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficient Induction of Th1-type Immune Responses to Hepatitis B Virus Antigens by DNA Prime-Adenovirus Boost
-
Lee CG, Yang SH, Park SH, Song MK, Choi SY, Sung YC
- KMID: 2150583
- Immune Netw.
- 2005 Mar;5(1):1-10.
- doi: 10.4110/in.2005.5.1.1
BACKGROUND: Chronic infection with hepatitis B virus (HBV) affects about 350 million people worldwide, which have a high risk of development of cirrhosis and hepatocellular carcinoma. Treatment of chronic HBV... -
- CITED
-
- Close
- SHARE
-
- Close
